InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the detailed record of transactions filed by Cochran John, 董事. Insider active across 2 companies, notably Aquestive Therapeutics, Inc.. Cumulatively, 2 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €132k. Activity tracked since 10 May 2021. The latest transaction was disclosed on 24 July 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Cochran John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
7,643.117 股@ US$19.63100.0% 占其流量Limited Liability Company UnitsSEC:0001628280-26-050148:0
标准退出：2026年10月22日 (T+90)
37,500 股0Common StockSEC:0001214659-21-006162:0
2 条申报中的 2 条
About Cochran John
John Cochran is a Director at Aquestive Therapeutics, Inc. In this role, he participates in the governance and strategy of the company. Aquestive Therapeutics, Inc. is a biopharmaceutical company specializing in developing innovative treatments. John Cochran brings his expertise in the health sector to help guide strategic decisions.
